Who owns OCULAR THERAPEUTIX, INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of OCUL from SEC Form 13F filings across 262 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 262 institutions disclosed 207.2M shares of OCULAR THERAPEUTIX, INC worth $2.03B — about 92.1% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
262
13F holders
$2.03B
value, 2026 filers
92.1%
of shares outstanding (207.2M sh)
38
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of OCUL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 32.8M | $322.5M | 0.0% | 14.6% | +0.6% |
| 2 | Deep Track Capital, LP | 19.7M | $193.3M | 2.8% | 8.8% | 0.0% |
| 3 | BlackRock, Inc. | 19.4M | $190.3M | 0.0% | 8.6% | +20.1% |
| 4 | Avoro Capital Advisors LLC | 12.5M | $123.1M | 1.1% | 5.6% | +1.8% |
| 5 | Summer Road LLC | 12.2M | $119.9M | 74.5% | 5.4% | +2.8% |
| 6 | Venrock Adviser, LLC | 10.3M | $101.6M | 3.1% | 4.6% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 8.8M | $86.7M | 0.0% | 3.9% | +1.3% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 7.6M | $74.9M | 0.0% | 3.4% | +29.3% |
| 9 | Logos Global Management LP | 5.3M | $52.0M | 2.2% | 2.4% | +37.7% |
| 10 | STATE STREET CORP | 5.2M | $51.4M | 0.0% | 2.3% | +11.1% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 5.0M | $49.3M | 0.0% | 2.2% | +10.9% |
| 12 | Point72 Asset Management, L.P. | 3.3M | $32.3M | 0.0% | 1.5% | -40.5% |
| 13 | DIMENSIONAL FUND ADVISORS LP | 2.8M | $27.3M | 0.0% | 1.2% | +328.4% |
| 14 | DELTEC ASSET MANAGEMENT LLC | 2.5M | $24.3M | 3.6% | 1.1% | +5.8% |
| 15 | Balyasny Asset Management L.P. | 2.3M | $22.3M | 0.0% | 1% | -15.7% |
| 16 | Octagon Capital Advisors LP | 2.1M | $20.4M | 1.8% | 0.9% | -34.5% |
| 17 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.0M | $19.4M | 0.0% | 0.9% | +23.7% |
| 18 | NORTHERN TRUST CORP | 1.8M | $17.7M | 0.0% | 0.8% | +17.9% |
| 19 | GOLDMAN SACHS GROUP INC | 1.8M | $17.3M | 0.0% | 0.8% | +58.7% |
| 20 | Nuveen, LLC | 1.7M | $16.7M | 0.0% | 0.8% | +312.9% |
| 21 | Woodline Partners LP | 1.7M | $16.4M | 0.1% | 0.7% | 0.0% |
| 22 | TCG Crossover Management, LLC | 1.6M | $16.2M | 0.4% | 0.7% | 0.0% |
| 23 | UBS Group AG | 1.6M | $15.2M | 0.0% | 0.7% | +2.0% |
| 24 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 1.6M | $15.2M | 0.0% | 0.7% | new |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.5M | $15.1M | 0.0% | 0.7% | +4.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.